Vor Biopharma Inc. Common Stock
$21.40
Market Cap
$1.27B
Shares Outstanding
59.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 5, 2021
Round Lot
100
Locale
US
Day Open
$21.92
Day High
$22.00
Day Low
$21.23
Volume
3.73M
VWAP
$21.42
Prev Close
$21.89
Transactions
--
Acc. Volume
--
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Vor Biopharma Inc. Common Stock (VOR) closed the 2026-09-18 session at $21.40, down 2.24% versus the previous close (-0.49). The stock opened at $21.92 and traded between $21.23 and $22.00 during that session. Session trading volume was 3.7M shares. The volume-weighted average price (VWAP) is $21.42.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Vor Biopharma Inc. Common Stock has a market capitalization of $1.27 billion. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. VOR is listed on the XNAS exchange. The company employs approximately 76 people. Vor Biopharma Inc. Common Stock is headquartered in BOSTON, MA. The recorded listing date is 2021-02-05.
On this page you can find market VOR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.